ibrutinib,zanubrutinib
beigene,janssen,abbvie
['leukemia', 'toci', 'lymphoma', 'zanubrutinib', 'cll', ' ibru', 'alpine', 'tianjin', 'beigene', 'bergen']
jennifer brown from shows that zanubrutinib is superior to ibrutinib for relapsed/refractory cll/sll for everything except for overall survival. #lba #ash22. published today in . 
Clinical Haematologist, marrow transplanter. Past President World WMDA and WBMT. Editor-in-Chief Internal Medicine Journal.